A study to test a medicine (fitusiran) for preventing bleeds in people with severe hemophilia who previously received preventive treatment with emicizumab

Trial Identifier: SFY17741
Sponsor: Sanofi
Start Date: March 2024
Primary Completion Date: May 2028
Study Completion Date: January 2030
Condition: Hemophilia

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations

Country Location
TAIWAN, PROVINCE OF CHINA, Podlaskie Taipei City, Podlaskie, TAIWAN, PROVINCE OF CHINA, 100
UNITED STATES, California Los Angeles, California, UNITED STATES, 90027